Alcohol Addiction Treatment
Understanding Alcohol Use Disorder
Alcohol use disorder (AUD) is a chronic, relapsing brain disease characterized by compulsive alcohol use, loss of control over intake, and negative emotional state when not drinking.
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), approximately 29.5 million Americans aged 12 and older had alcohol use disorder in 2022. Despite its prevalence, only about 8% of individuals with AUD receive treatment. The World Health Organization identifies alcohol as a leading risk factor for global disease burden, contributing to over 3 million deaths annually worldwide.
AUD exists on a spectrum from mild to severe, diagnosed using DSM-5 criteria that include tolerance (needing more alcohol to achieve the same effect), withdrawal symptoms when stopping, drinking more or longer than intended, unsuccessful efforts to cut down, spending significant time obtaining or recovering from alcohol, giving up important activities, and continued use despite physical or psychological problems caused by drinking.
Chronic alcohol consumption causes profound neurobiological changes. Alcohol enhances GABAergic neurotransmission (producing sedative effects) while inhibiting glutamatergic signaling (reducing excitatory activity). Over time, the brain compensates by downregulating GABA receptors and upregulating NMDA glutamate receptors. When alcohol is removed, this neuroadaptation creates dangerous hyperexcitability, manifesting as anxiety, tremors, seizures, and potentially life-threatening delirium tremens. Additionally, alcohol disrupts dopamine reward pathways, creating powerful cravings and reinforcing continued use despite negative consequences.
Risk Factors for Alcohol Use Disorder
- Genetics: Family history accounts for approximately 50% of AUD risk
- Early onset: Drinking before age 15 increases lifetime AUD risk fourfold
- Mental health disorders: Depression, anxiety, PTSD, and bipolar disorder significantly increase risk
- Trauma history: Childhood abuse, neglect, or adverse experiences correlate with higher AUD rates
- Social environment: Peer pressure, cultural norms, and alcohol availability influence risk
- Chronic stress: Prolonged stress dysregulates stress response systems, increasing vulnerability
Signs & Symptoms of Alcohol Use Disorder
Recognizing the signs of alcohol addiction is the first step toward recovery. Symptoms range from behavioral changes to severe physical dependence.
Behavioral & Psychological Signs
- Inability to limit drinking once started
- Strong cravings or urges to drink
- Drinking alone or in secret
- Neglecting responsibilities at work, school, or home
- Continuing to drink despite relationship problems
- Giving up activities that were once important
- Drinking in dangerous situations (driving, operating machinery)
- Blackouts or memory loss during drinking episodes
- Irritability, mood swings, or depression when not drinking
- Denying or minimizing the extent of drinking
Physical Signs & Withdrawal Symptoms
- Increased tolerance (needing more to feel effects)
- Tremors or shaking hands, especially in the morning
- Sweating, rapid heart rate, or elevated blood pressure
- Nausea, vomiting, or loss of appetite
- Insomnia or disturbed sleep patterns
- Anxiety or panic attacks when not drinking
- Seizures (in severe cases of withdrawal)
- Hallucinations (visual, auditory, or tactile)
- Delirium tremens (DTs): confusion, disorientation, severe agitation
- Flushed skin, broken capillaries on face
- Jaundice (yellowing skin/eyes from liver damage)
- Unexplained injuries or bruising from accidents while intoxicated
Health Consequences of Chronic Alcohol Use
Prolonged alcohol consumption damages virtually every organ system in the body, leading to serious medical complications and reduced life expectancy.
Liver Disease
The liver metabolizes over 90% of ingested alcohol, making it particularly vulnerable to alcohol-related damage. Progression typically follows three stages: fatty liver (steatosis) develops in 90% of heavy drinkers and is reversible with abstinence; alcoholic hepatitis involves inflammation and liver cell death, with severe cases carrying 30-50% mortality; cirrhosis represents irreversible scarring and loss of liver function, leading to portal hypertension, esophageal varices, ascites, hepatic encephalopathy, and increased liver cancer risk. According to the CDC, chronic liver disease and cirrhosis caused over 51,000 deaths in 2021, with alcohol being the primary cause.
Cardiovascular Disease
Chronic alcohol consumption causes alcoholic cardiomyopathy (weakening of heart muscle), atrial fibrillation and other arrhythmias, hypertension (high blood pressure), increased stroke risk, and coronary artery disease. Even moderate drinking elevates blood pressure; heavy drinking significantly increases cardiovascular mortality. The American Heart Association notes that excessive alcohol use is responsible for approximately 2.7 million cardiovascular deaths annually worldwide.
Cancer
The International Agency for Research on Cancer classifies alcohol as a Group 1 carcinogen. Alcohol increases risk for cancers of the mouth, pharynx, larynx, esophagus, liver, colon, rectum, and breast. Risk is dose-dependent—even light to moderate drinking (1-2 drinks daily) increases cancer risk, particularly for breast cancer in women. Alcohol metabolism produces acetaldehyde, a toxic compound that damages DNA and proteins, while also impairing DNA repair mechanisms and acting as a solvent for other carcinogens.
Neurological Damage
Alcohol neurotoxicity causes brain shrinkage (particularly frontal lobes and cerebellum), peripheral neuropathy (nerve damage causing numbness, tingling, pain in extremities), Wernicke-Korsakoff syndrome (thiamine deficiency leading to confusion, memory loss, confabulation, and permanent cognitive impairment), cerebellar degeneration (affecting balance and coordination), and increased risk for hemorrhagic stroke. Chronic use impairs executive function, decision-making, impulse control, and memory formation even without diagnosed Wernicke-Korsakoff syndrome.
Gastrointestinal Complications
Beyond liver disease, alcohol damages the entire GI tract: gastritis and peptic ulcers from irritation of stomach lining; pancreatitis (acute and chronic inflammation of the pancreas, extremely painful and potentially fatal); malabsorption of nutrients (particularly B vitamins, folate, vitamin D); increased intestinal permeability ("leaky gut"); and esophageal varices (enlarged, fragile veins in the esophagus that can rupture and cause life-threatening bleeding).
Immune System Suppression & Other Effects
Chronic alcohol use impairs immune function, increasing susceptibility to pneumonia, tuberculosis, and other infections. Additional effects include: bone loss and increased fracture risk; sexual dysfunction and hormonal disruptions; increased risk of dementia in older adults; complications during pregnancy including fetal alcohol spectrum disorders; and significantly elevated risk for mental health conditions including depression, anxiety disorders, and suicide.
Our Alcohol Addiction Treatment Approach
RECO Health provides comprehensive, medically supervised treatment for alcohol use disorder using FDA-approved medications, evidence-based therapy, and holistic support.
Medical Detoxification
Alcohol withdrawal can be life-threatening and should never be attempted without medical supervision. Our detox program provides 24/7 medical monitoring, medication-assisted withdrawal management, and comprehensive support during the acute phase of recovery.
CIWA-Ar Protocol
We use the Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) protocol to objectively measure withdrawal severity and guide medication administration. This validated 10-item scale assesses nausea, tremor, sweating, anxiety, agitation, tactile/auditory/visual disturbances, headache, and orientation.
Medication management: Benzodiazepines (typically chlordiazepoxide, lorazepam, or diazepam) are administered based on CIWA-Ar scores to prevent seizures, reduce withdrawal severity, and minimize DT risk. We also provide thiamine (vitamin B1) to prevent Wernicke encephalopathy, multivitamins, electrolyte replacement, and symptom-specific medications for nausea, headache, and insomnia.
Withdrawal timeline: Symptoms typically begin 6-12 hours after last drink, peak at 24-72 hours, and gradually subside over 5-7 days. However, post-acute withdrawal syndrome (PAWS) including mood disturbances, anxiety, sleep problems, and cognitive difficulties may persist for weeks to months, which we address through ongoing clinical care.
FDA-Approved Medications for AUD
Naltrexone (Oral & Vivitrol)
Mechanism: Opioid receptor antagonist that blocks the rewarding effects of alcohol and reduces cravings. Evidence: Clinical trials show 25-30% reduction in heavy drinking days and increased abstinence rates. Formulations: Daily oral tablet (50mg) or monthly extended-release injection (Vivitrol 380mg), which improves medication adherence. Safety: Generally well-tolerated; cannot be used with current opioid use.
Acamprosate (Campral)
Mechanism: Modulates glutamate and GABA neurotransmission disrupted by chronic alcohol use, helping restore neurochemical balance. Reduces cravings and supports abstinence maintenance. Evidence: Meta-analyses show significant improvement in continuous abstinence rates compared to placebo. Dosing: 666mg three times daily (two tablets TID). Best for: Individuals committed to abstinence; most effective when started after completing detox.
Disulfiram (Antabuse)
Mechanism: Inhibits aldehyde dehydrogenase, causing accumulation of acetaldehyde when alcohol is consumed. This produces severely unpleasant reactions including flushing, nausea, vomiting, headache, and chest pain—creating a powerful deterrent to drinking. Dosing: 250-500mg daily. Best for: Highly motivated individuals who want a "chemical barrier" to impulsive drinking. Requirements: Requires abstinence from all alcohol-containing products (mouthwash, cough syrup, etc.) and careful patient selection and education.
Our addiction medicine physicians carefully evaluate each individual to determine the most appropriate medication(s) based on drinking patterns, medical history, treatment goals, and co-occurring conditions. Many individuals benefit from combination therapy or sequential trials of different medications.
Evidence-Based Psychotherapy
Cognitive Behavioral Therapy (CBT)
Identifies and modifies distorted thinking patterns and maladaptive behaviors related to drinking. Develops coping skills, triggers management, and relapse prevention strategies.
Motivational Interviewing (MI)
Client-centered counseling approach that explores and resolves ambivalence about change, enhances intrinsic motivation, and strengthens commitment to recovery goals.
Dialectical Behavior Therapy (DBT)
Teaches mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness skills. Particularly effective for individuals with co-occurring borderline personality disorder or emotional dysregulation.
Trauma-Focused Therapy
EMDR, trauma-focused CBT, and other modalities address underlying trauma that often contributes to alcohol use. Integrated trauma and substance abuse treatment improves long-term outcomes.
12-Step Facilitation
Introduces Alcoholics Anonymous (AA) principles, encourages meeting attendance, supports sponsor relationships, and helps integrate 12-step philosophy into recovery journey.
Family Therapy
Addresses family dynamics, repairs relationships damaged by addiction, educates loved ones about AUD, and builds family support systems essential for long-term recovery.
Levels of Care for Alcohol Addiction
RECO Health offers a full continuum of evidence-based treatment services, allowing seamless transitions as your recovery progresses.
Medical Detoxification
24/7 medical supervision, CIWA-Ar protocol-guided medication management, and comprehensive support during acute alcohol withdrawal. Duration: 5-7 days typically, longer if medically complex.
Residential Treatment (RTC)
Immersive 24/7 treatment environment with structured programming including individual therapy, group counseling, psychoeducation, medication management, holistic therapies, and peer support. Recommended duration: 30-90 days based on ASAM criteria and individual progress.
Partial Hospitalization Program (PHP)
Step-down from residential or appropriate for individuals who don't require 24/7 supervision. Programming 5-6 days/week, 6+ hours/day. Includes therapy, medication management, life skills training, and clinical monitoring while returning home evenings. Duration: 2-4 weeks typically.
Intensive Outpatient Program (IOP)
Structured treatment 3-5 days/week, 3 hours/day while living at home or in sober living. Combines group therapy, individual counseling, relapse prevention, and recovery skills development. Allows gradual reintegration into work, school, and family life. Duration: 6-12 weeks.
Outpatient Continuing Care
Ongoing individual therapy, medication management, and periodic check-ins to support long-term recovery. Frequency decreases over time (weekly → biweekly → monthly) based on stability. Maintains therapeutic relationship and provides accountability during vulnerable transition periods.
ASAM Criteria-Based Placement
We use the American Society of Addiction Medicine (ASAM) criteria to determine appropriate level of care based on six dimensions: acute intoxication/withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness to change, relapse potential, and recovery environment. This evidence-based approach ensures you receive the right intensity of treatment at the right time, with seamless transitions between levels as clinically indicated.
Frequently Asked Questions About Alcohol Addiction Treatment
Alcohol withdrawal can be life-threatening and should never be attempted without medical supervision. Severe alcohol withdrawal syndrome, known as delirium tremens (DTs), occurs in approximately 5% of individuals undergoing withdrawal and carries a mortality rate of 5-15% if untreated.
Symptoms of DTs include severe confusion, hallucinations, seizures, dangerously elevated heart rate and blood pressure, and hyperthermia. Withdrawal seizures typically occur 12-48 hours after the last drink and can progress to status epilepticus, a medical emergency.
Even without DTs, alcohol withdrawal causes severe autonomic hyperactivity including tremors, sweating, anxiety, nausea, and insomnia. At RECO Health, we provide 24/7 medical monitoring during detox, use benzodiazepines to prevent seizures and reduce withdrawal severity, and employ the Clinical Institute Withdrawal Assessment (CIWA-Ar) protocol to guide medication dosing.
The FDA has approved three medications for alcohol use disorder: naltrexone, acamprosate, and disulfiram.
Naltrexone (oral or extended-release injectable Vivitrol) blocks opioid receptors, reducing alcohol cravings and the rewarding effects of drinking. Clinical trials show naltrexone reduces heavy drinking days by 25-30%.
Acamprosate (Campral) modulates glutamate and GABA neurotransmission disrupted by chronic alcohol use, reducing cravings and supporting abstinence.
Disulfiram (Antabuse) creates unpleasant reactions (nausea, flushing, headache) when combined with alcohol, serving as a deterrent.
Our addiction medicine physicians also prescribe medications for co-occurring conditions like anxiety, depression, and sleep disorders, which are present in over 50% of individuals with AUD.
Treatment duration varies based on severity of alcohol use disorder, medical complications, co-occurring disorders, and individual progress. Medical detox typically lasts 5-7 days, though withdrawal symptoms may persist for several weeks.
SAMHSA recommends a minimum of 90 days of treatment for the best outcomes. Most individuals begin with residential treatment (30-90 days) followed by partial hospitalization (2-4 weeks), intensive outpatient (6-12 weeks), and standard outpatient care.
Research from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) shows longer treatment duration strongly correlates with sustained abstinence. We develop individualized treatment plans based on ASAM criteria, adjusting level of care as you progress.
For individuals diagnosed with alcohol use disorder (AUD), complete abstinence is the recommended goal. AUD is a chronic brain disease characterized by neurobiological changes that persist long after drinking stops.
Research shows that individuals with moderate to severe AUD cannot return to controlled drinking—attempts at moderation typically result in relapse to problematic use. The neurochemical adaptations caused by chronic alcohol exposure (downregulated GABA receptors, upregulated NMDA receptors, dysregulated dopamine reward pathways) create lasting vulnerability to loss of control.
While harm reduction approaches may be appropriate for some individuals with mild AUD, our clinical experience and evidence-based guidelines support abstinence as the safest, most effective approach for lasting recovery.
Chronic alcohol use causes widespread organ damage. Liver disease progresses from fatty liver to alcoholic hepatitis to cirrhosis, which is irreversible and potentially fatal. Alcohol is a Class 1 carcinogen, increasing risk for cancers of the mouth, throat, esophagus, liver, colon, and breast.
Cardiovascular effects include cardiomyopathy, arrhythmias, hypertension, and increased stroke risk. Neurological complications include peripheral neuropathy, cerebellar degeneration, and Wernicke-Korsakoff syndrome (thiamine deficiency causing permanent memory impairment).
Chronic alcohol use suppresses immune function, increases infection risk, causes pancreatitis, and leads to bone loss. Mental health consequences include increased depression, anxiety, and suicide risk.
The good news: many alcohol-related health problems improve significantly with sustained abstinence, especially when caught before irreversible damage occurs.
Yes. The Mental Health Parity and Addiction Equity Act (MHPAEA) and the Affordable Care Act (ACA) require most insurance plans to cover substance use disorder treatment at the same level as medical/surgical care. This includes detox, residential treatment, outpatient therapy, and medication-assisted treatment.
Coverage details vary by plan, but most cover the majority of treatment costs after deductible and copays. RECO Health accepts most major insurance plans and our admissions team provides free, confidential insurance verification before admission. We'll explain your coverage, out-of-pocket costs, and payment options.
If you're uninsured, we offer private pay options and can discuss financial arrangements.